AHMED, H. et al. Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis. ASIDE Gastroenterology, v. 2, n. 4, p. 1–7, 27 Jul.2026.